Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
A3334
Cat. No.:
OB0425LY-099
Appearance:
Solid
Purity:
99.64%
Identity:
Confirmed by LC-MS.
Size:
Add to basket
Product Overview
Description:
A3334 is an inhibitor widely used in obesity research.
Synonyms:
854171-31-6; 5-Methoxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-2-ol
CAS No.:
854171-31-6
Compound CID:
136026170
Formula:
C17H13N3O3
Formula Weight:
307.3
Specification
Target:
β-catenin; Wnt
Pathway:
Stem cell/Wnt
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
A3334 can be used to study obesity, diabetes and non-alcoholic fatty liver disease.
